Residual asthmatic inflammation in the peripheral airway under the condition of total control levels with the full 25 points of ACT scores

H. Ohbayashi, N. Shibata, M. Adachi (Mizunami, Tokyo, Japan)

Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Session: Asthma aspect of diagnosis and criteria for follow-up
Session type: Thematic Poster Session
Number: 527
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ohbayashi, N. Shibata, M. Adachi (Mizunami, Tokyo, Japan). Residual asthmatic inflammation in the peripheral airway under the condition of total control levels with the full 25 points of ACT scores. Eur Respir J 2010; 36: Suppl. 54, 527

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of Nε-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004

Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007



Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Relationship between sputum inflammatory parameters, symptom scores and reduced quality of life in asthmatic patients
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003

The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008


Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012

High intensity interval training control inflammation in a lung allergic model.
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020


Anti-IL17 treatment controls airway asthmatic responses exacerbated by LPS
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Baseline inflammation in the lower airways of allergic rhinitic subjects compared to normal subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 270s
Year: 2001

Correlation of bronchial inflammation pattern and airway response to cold stimulus in patients with uncontrolled asthma
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Responsiveness of the asthma control test (ACT) to changes in specialists ratings of asthma control and FEV1
Source: Eur Respir J 2004; 24: Suppl. 48, 85s
Year: 2004

Baseline airway inflammation may be a determinant of ozone response in asthmatic patients
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012

Effect of treatment with positive airway pressure in bronchial hyper responsiveness in asthmatic children and adolescents.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017


Changes in lung function and airway eosinophilia after reduction of ICS treatment and recurrence of asthmatic symptoms
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003

Correlation between the asthma control, bronchial inflammation and airway response to hypoosmotic stimulus
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020


Current control, airway inflammation, and subsequent exacerbation in patients with asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010